As global markets navigate the pressures of rising U.S. Treasury yields and tepid economic growth, small-cap stocks have faced particular challenges, with indices like the Russell 2000 showing notable ...

Marksans Pharma recorded its fiscal fourth quarter earnings with profit at Rs 78.29 crore, down 4.4 per cent in comparison to Rs 81.93 crore reported during the fourth quarter of FY23. It posted ...

Marksans Pharma has received approval from the US health regulator for loratadine liquid filled capsules, used for treatment of allergies, in the American market. The company has been granted the ...

Belt Hold Bullish 1H 68 Oct 22, 2024 11:00PM ...

Marksans Pharma Ltd share price was up by 0.69% from the previous closing price of ₹289.65. Who are peers of Marksans Pharma Ltd? The peers of Marksans Pharma Ltd are Sun Pharmaceuticals ...

Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April, 1982. Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals ...

Trading window for the designated persons of Marksans Pharma Limited will remain closed from 1st July, 2024 until 48 hours after announcement of Unaudited Financial Results for the quarter ended ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Engulfing Bearish 30 69 Oct 14, 2024 04:30 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...